Buprenorphine Cost Effectiveness

More documents

Recommendations

Info

Current Study • To evaluate the cost-effectiveness of long-term officebased buprenorphine treatment compared to no treatment for clinically stable patients – Assume patients are unwilling or unable to engage in methadone maintenance treatment – Medical perspective taking into account patient benefits measured in QALYs • To evaluate the impact of uncertainty about model inputs on cost-effectiveness results – Price of buprenorphine – Duration of treatment – Quality of life on/off buprenorphine 12
Enter In Treatment Off Drugs In Treatment On Drugs Model Off Treatment Off Drugs Off Treatment On Drugs Note: Separate models run for injection drug users (IDUs) and non-IDUs 13
Page 1 and 2: Buprenorphine Cost Effectiveness Br
Page 3 and 4: Buprenorphine Cost • Cost has bee
Page 5 and 6: Cost-effectiveness ≠ Cost saving
Page 7 and 8: Questions Policy Makers Should Ask
Page 9 and 10: Cost-effectiveness vs cost-benefit?
Page 11: Published Cost-Effectiveness Studie
Page 15 and 16: Cohort Retention In Treatment By Mo
Page 17 and 18: Limitations • Cohort treated at a
Page 19: • David Fiellin, MD • Jared Lef

Buprenorphine Cost Effectiveness

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?